![Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology | ADA Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology | ADA](https://diabetes.org/sites/default/files/inline-images/SCI_2022_SOC.jpg)
Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology | ADA
![2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-019-05039-w/MediaObjects/125_2019_5039_Fig1_HTML.png)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4729-5/MediaObjects/125_2018_4729_Fig1_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![GBA Health Connect - Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes by American Diabetes Association (ADA) 2022 guideline GBA Health Connect - Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes by American Diabetes Association (ADA) 2022 guideline](https://gbahealthconnect.com/img/articles/17/20221116_GBA%20articles_ADA_v2_Eng.jpg)
GBA Health Connect - Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes by American Diabetes Association (ADA) 2022 guideline
![ADA/EASD Consensus Update on Management of Hyperglycemia in Type 2 Diabetes – Report Published in Diabetes Care - L'Observateur | L'Observateur ADA/EASD Consensus Update on Management of Hyperglycemia in Type 2 Diabetes – Report Published in Diabetes Care - L'Observateur | L'Observateur](https://www.lobservateur.com/wp-content/uploads/sites/21/2022/09/unnamed-27.png?w=484)
ADA/EASD Consensus Update on Management of Hyperglycemia in Type 2 Diabetes – Report Published in Diabetes Care - L'Observateur | L'Observateur
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig1_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia](https://diabetologia-journal.org/wp-content/uploads/2018/09/Fig-2-for-EASD-ADA.jpg)
New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence – Diabetologia
![Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog](https://blog.endokrinologie.net/wp-content/uploads/2018/11/ADA-EASD-Guidelines-2018-2.jpg)
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig3_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet](https://diabetesonthenet.com/wp-content/uploads/imagesmol/dotngmdJDN034_Down_Figure_1_HR.png)
The new ADA/EASD guideline: A huge leap forward in the treatment of type 2 diabetes - DiabetesontheNet
![Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05787-2/MediaObjects/125_2022_5787_Fig2_HTML.png)